Literature DB >> 21666406

Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting.

Anthony D Harris1, J Kristie Johnson, Kerri A Thom, Daniel J Morgan, Jessina C McGregor, Adebola O Ajao, Anita C Moore, Angela C Comer, Jon P Furuno.   

Abstract

Risk factors for development of intestinal colonization by imipenem-resistant Pseudomonas aeruginosa (IRPA) may differ between those who acquire the organism via patient-to-patient transmission versus by antibiotic selective pressure. The aim of this study was to quantify potential risk factors for the development of IRPA not due to patient-to-patient transmission.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21666406      PMCID： PMC3312468          DOI： 10.1086/660763

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  10 in total

Review 1.  Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review.

Authors:  A D Harris; T B Karchmer; Y Carmeli; M H Samore
Journal:  Clin Infect Dis       Date:  2001-03-21       Impact factor: 9.079

2.  Role of hospital stay and antibiotic use on Pseudomonas aeruginosa gastrointestinal colonization in hospitalized patients.

Authors:  D Lepelletier; N Caroff; D Riochet; P Bizouarn; A Bourdeau; F Le Gallou; E Espaze; A Reynaud; H Richet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

Review 3.  Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front.

Authors:  Marin H Kollef
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

4.  Increasing prevalence of gastrointestinal colonization with ceftazidime-resistant gram-negative bacteria among intensive care unit patients.

Authors:  Kerri A Thom; Judith A Johnson; Sandra M Strauss; Jon P Furuno; Eli N Perencevich; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2007-09-26       Impact factor: 3.254

5.  The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable.

Authors:  M J Bonten; S Slaughter; A W Ambergen; M K Hayden; J van Voorhis; C Nathan; R A Weinstein
Journal:  Arch Intern Med       Date:  1998-05-25

6.  Assessment of materials commonly utilized in health care: implications for bacterial survival and transmission.

Authors:  Mary G Lankford; Susan Collins; Larry Youngberg; Denise M Rooney; John R Warren; Gary A Noskin
Journal:  Am J Infect Control       Date:  2006-06       Impact factor: 2.918

7.  Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.

Authors:  S Panagea; C Winstanley; M J Walshaw; M J Ledson; C A Hart
Journal:  J Hosp Infect       Date:  2005-02       Impact factor: 3.926

8.  NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.

Authors:  Alicia I Hidron; Jonathan R Edwards; Jean Patel; Teresa C Horan; Dawn M Sievert; Daniel A Pollock; Scott K Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2008-11       Impact factor: 3.254

9.  The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit.

Authors:  J Kristie Johnson; Gwen Smith; Mary S Lee; Richard A Venezia; O Colin Stine; James P Nataro; William Hsiao; Anthony D Harris
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

10.  Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.

Authors:  C Peña; A Guzmán; C Suarez; M A Dominguez; F Tubau; M Pujol; F Gudiol; J Ariza
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191
  10 in total
  16 in total

1.  Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.

Authors:  Y-A Que; H Lazar; M Wolff; B François; P-F Laterre; E Mercier; J Garbino; J-L Pagani; J-P Revelly; E Mus; A Perez; M Tamm; J-J Rouby; Q Lu; J Chastre; P Eggimann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-24       Impact factor: 3.267

2.  The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units.

Authors:  Yamin Zou; Jiangping Lian; Ying Di; Haisheng You; Hongping Yao; Junhui Liu; Yalin Dong
Journal:  Int J Clin Pharm       Date:  2017-11-14

3.  Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.

Authors:  J Kristie Johnson; Gwen L Robinson; Lisa L Pineles; Adebola O Ajao; LiCheng Zhao; Jennifer S Albrecht; Anthony D Harris; Kerri A Thom; Jon P Furuno
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  Electronically Available Comorbid Conditions for Risk Prediction of Healthcare-Associated Clostridium difficile Infection.

Authors:  Anthony D Harris; Alyssa N Sbarra; Surbhi Leekha; Sarah S Jackson; J Kristie Johnson; Lisa Pineles; Kerri A Thom
Journal:  Infect Control Hosp Epidemiol       Date:  2018-02-05       Impact factor: 3.254

Review 5.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

6.  Use of Comparative Genomics To Characterize the Diversity of Acinetobacter baumannii Surveillance Isolates in a Health Care Institution.

Authors:  Lalena Wallace; Sean C Daugherty; Sushma Nagaraj; J Kristie Johnson; Anthony D Harris; David A Rasko
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 7.  The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance.

Authors:  Melinda M Pettigrew; J Kristie Johnson; Anthony D Harris
Journal:  Ann Epidemiol       Date:  2016-03-08       Impact factor: 3.797

8.  Pseudomonas aeruginosa Colonization in the Intensive Care Unit: Prevalence, Risk Factors, and Clinical Outcomes.

Authors:  Anthony D Harris; Sarah S Jackson; Gwen Robinson; Lisa Pineles; Surbhi Leekha; Kerri A Thom; Yuan Wang; Michelle Doll; Melinda M Pettigrew; J Kristie Johnson
Journal:  Infect Control Hosp Epidemiol       Date:  2016-02-01       Impact factor: 3.254

9.  Comorbidity and severity-of-illness risk adjustment for hospital-onset Clostridioides difficile infection using data from the electronic medical record.

Authors:  Stephanie M Cabral; Katherine E Goodman; Natalia Blanco; Surbhi Leekha; Larry S Magder; Gita Nadimpalli; Lisa Pineles; Kerri A Thom; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2020-12-17       Impact factor: 6.520

10.  Colonization pressure: a critical parameter in the epidemiology of antibiotic-resistant bacteria.

Authors:  Marc J M Bonten
Journal:  Crit Care       Date:  2012-07-31       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.